iTeos kündigt strategische Prioritäten für 2024 und voraussichtliche Meilensteine an
– Klinische Daten aus dem TIGIT-Programm wer
Read more
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
2023 Total Revenue of ~$399.
Read moreAkoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
MARLBOROUGH, Mass., Jan.
Read moreAlbertsons Media Collective Selects Capgemini as its Global Agency Partner for Media Planning, Media Operations and Content Creation
Capgemini’s intelligent process automation and gen
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Ltd. – EH
NEW YORK, Jan.
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of National Instruments Corporation – NATI
NEW YORK, Jan.
Read moreSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ChargePoint Holdings, Inc. – CHPT
NEW YORK, Jan.
Read moreShowBiz Minute: Majors, Streisand, Auction
Jury deliberating whether actor Jonathan Majors assaulted a girlfriend; Barbra Streisand to receive lifetime achievement award at SAG Awards; E.T.,...
Read moreFormer Jaguars financial manager pleads guilty to stealing $22M
Former Jacksonville Jaguars financial manager Amit Patel pleaded guilty to federal charges Thursday.
Read moreEXPENSIFY SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Expensify To Contact Him Directly To Discuss Their Options
James (Josh) Wilson Faruqi & Faruqi, LLP Ja
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS